Insider Trading Summary for Lexicon Pharmaceuticals, Inc. (LXRX): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
29-Apr-24 4:18 PM View:	28-Apr-24 Option Exercise 0	Lefkowitz Robert J Md Director		Lexicon Pharmaceuticals, Inc. - LXRX	20% 40.33K to 48.36K	0	0	--	--	Show Txns Hide Txns

29-Apr-24 4:17 PM View:	28-Apr-24 Option Exercise 0	Barker Sam L Director		Lexicon Pharmaceuticals, Inc. - LXRX	10% 79.62K to 87.65K	0	0	--	--	Show Txns Hide Txns

29-Apr-24 4:20 PM View:	28-Apr-24 Option Exercise 0	Sobecki Christopher J Director		Lexicon Pharmaceuticals, Inc. - LXRX	5% 159.02K to 167.06K	0	0	--	--	Show Txns Hide Txns

29-Apr-24 4:16 PM View:	28-Apr-24 Option Exercise 0	Amouyal Philippe Director		Lexicon Pharmaceuticals, Inc. - LXRX	3% 240.33K to 248.36K	0	0	--	--	Show Txns Hide Txns

29-Apr-24 4:21 PM View:	28-Apr-24 Option Exercise 0	Swain Judith L Director		Lexicon Pharmaceuticals, Inc. - LXRX	20% 40.33K to 48.36K	0	0	--	--	Show Txns Hide Txns

14-May-24 5:17 PM View:	10-May-24 Option Exercise 0	Artal International Sca Director 10% Owner		Lexicon Pharmaceuticals, Inc. - LXRX	100% 0 to 175.1M	0	0	--	--	Show Txns Hide Txns

29-Apr-24 4:17 PM View:	28-Apr-24 Option Exercise 0	Debbane Raymond Director		Lexicon Pharmaceuticals, Inc. - LXRX	0% 6.79M to 6.8M	0	0	--	--	Show Txns Hide Txns

29-Feb-24 4:30 PM View:	28-Feb-24 Payment of Exercise ($63.95K)	Main Alan J EVP, Innov & Chem Sciences		Lexicon Pharmaceuticals, Inc. - LXRX	20% 212.59K to 255.72K	0	0	--	--	Show Txns Hide Txns

29-Feb-24 4:28 PM View:	28-Feb-24 Payment of Exercise ($81.91K)	Granowitz Craig B SVP, Chief Medical Officer		Lexicon Pharmaceuticals, Inc. - LXRX	214% 15.19K to 47.63K	0	0	--	--	Show Txns Hide Txns

29-Feb-24 10:00 PM View:	28-Feb-24 Payment of Exercise ($30.90K)	Alexander Kristen VP, Finance and Accounting		Lexicon Pharmaceuticals, Inc. - LXRX	57% 30.35K to 47.8K	0	0	--	--	Show Txns Hide Txns

29-Feb-24 10:00 PM View:	28-Feb-24 Payment of Exercise ($63.80K)	Kassler-Taub Kenneth B. SVP, Regulatory & QA		Lexicon Pharmaceuticals, Inc. - LXRX	36% 119.63K to 162.67K	0	0	--	--	Show Txns Hide Txns

29-Feb-24 10:00 PM View:	28-Feb-24 Payment of Exercise ($58.75K)	McDermott Wendy VP, Human Resources		Lexicon Pharmaceuticals, Inc. - LXRX	85% 28.48K to 52.69K	0	0	--	--	Show Txns Hide Txns

29-Feb-24 10:00 PM View:	28-Feb-24 Payment of Exercise ($160.79K)	Coats Lonnel Chief Executive Officer Director		Lexicon Pharmaceuticals, Inc. - LXRX	20% 914.36K to 1.1M	0	0	--	--	Show Txns Hide Txns

29-Feb-24 10:00 PM View:	28-Feb-24 Payment of Exercise ($67.08K)	Crum Brian T SVP, General Counsel & Secr.		Lexicon Pharmaceuticals, Inc. - LXRX	32% 134.8K to 177.5K	0	0	--	--	Show Txns Hide Txns

29-Feb-24 10:00 PM View:	28-Feb-24 Payment of Exercise ($98.75K)	Wade Jeffrey L President and COO		Lexicon Pharmaceuticals, Inc. - LXRX	23% 264.34K to 324.21K	0	0	--	--	Show Txns Hide Txns

Lexicon Pharmaceuticals, Inc. (LXRX)

Last Year

23-Nov-23 -- 22-Nov-24

Company Sentiment

Diagnostic Substances

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	0	--